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Abstract
Background: Several local attempts to introduce integrated care in the English National Health Service have been tried, with limited 
success. The Northwest London Integrated Care Pilot attempts to improve the quality of care of the elderly and people with diabetes by 
providing a novel integration process across primary, secondary and social care organisations. It involves predictive risk modelling, care 
planning, multidisciplinary management of complex cases and an information technology tool to support information sharing. This paper 
sets out the evaluation approach adopted to measure its effect.
Study design: We present a mixed methods evaluation methodology. It includes a quantitative approach measuring changes in service 
utilization, costs, clinical outcomes and quality of care using routine primary and secondary data sources. It also contains a qualitative 
component, involving observations, interviews and focus groups with patients and professionals, to understand participant experiences 
and to understand the pilot within the national policy context.
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Introduction
Integrated care refers to many different models of care 
[1] yet underlying these is a model where the patient’s 
journey through the system of care is made as simple 
as possible. Integration of care is expected to improve 
quality of care, patient safety and cost effectiveness 
[2–4]. As a result, the English Department of Health 
has been actively encouraging integration of care 
within local health economies, and included a duty to 
encourage integration in national legislation [5].
Getting integrated care right, and then demonstrat-
ing its effectiveness, is a clinical, organisational and 
research challenge. Several local attempts to intro-
duce integrated care in the English National Health 
Service (NHS) have been tried, with limited success 
[6]. Results of the national Integrated Care Pilot pro-
gramme showed that despite some improvements in 
process, and staff perceptions that care was being 
integrated, the pilot programmes achieved only limited 
improvements in clinical effectiveness and reduction in 
cost, and had little effect on patient satisfaction [7].
For the integrated care agenda to proceed, robustly 
evaluated examples in real-world conditions are 
needed to examine effectiveness, justify investment 
and consider their potential for implementation on a 
large-scale. In this paper, we describe a comprehensive 
evaluation approach that assesses multiple aspects of 
a large and complex integrated care intervention in 
London known as the North West London Integrated 
Care Pilot (NWL ICP). The evaluation involves several 
work streams that assess the broad aims of the pilot 
including how it fits within the wider health economy, its 
impact on clinical outcomes and cost, and the patients’ 
and professionals’ experience of integrated care.
The intervention
The aim of the NWL ICP is to improve care for 15,000 
people with diabetes and 22,000 people over the age 
of 75 in northwest London. It seeks to improve the 
quality of care yet at the same time reduce emergency 
admissions and the overall cost of care. It is a large, 
complex intervention covering over one hundred gen-
eral practices, five local authorities, two mental health 
trusts, five primary care trusts, two acute hospital trusts 
and two voluntary organisations. The population cov-
ered is typical of inner London, with pockets of extreme 
affluence and deprivation side by side in an area of 
high population density.
As described in Harris et al. [8], the approach taken in 
NWL ICP contains several interventions including: risk 
stratification using the combined predictive model; care 
planning across care settings; multi-disciplinary group 
(MDG) meetings; new financial incentives for partici-
pating organisations; and a new information technol-
ogy (IT) system to facilitate sharing of information and 
patient records between providers (see Box 1). The 
MDG meetings are designed to deliver joined-up care 
by bringing different health care professionals together 
(including GPs, hospital specialists, mental health 
care, community nursing, social care, and other allied 
health care professionals) to discuss the management 
of those with diabetes or older than 75 years that have 
been identified as having the most complex needs. 
Care plans are agreed in these meetings, which can 
then be monitored using the IT tool. The MDGs also 
have a secondary aim to improve interaction between 
primary, community, social and hospital care teams, 
hopefully leading to enhanced delivery models. The IT 
tool has been developed for the intervention and allows 
the various partner organizations to share, store, and 
analyse patient data. In particular, it allows referral 
support, performance management and risk manage-
ment to take place, combining data from the various 
organizations in a central secure database. The NWL 
ICP is governed by an unincorporated association of 
its constituent organisations, with a regular manage-
ment board chaired by an independent representative. 
It has a small dedicated management team to run the 
pilot on a day-to-day basis.
Theory and discussion: This study considers the complexity of evaluating a large, multi-organisational intervention in a changing health-
care economy. We locate the evaluation within the theory of evaluation of complex interventions. We present the specific challenges faced 
by evaluating an intervention of this sort, and the responses made to mitigate against them.
Conclusions: We hope this broad, dynamic and responsive evaluation will allow us to clarify the contribution of the pilot, and provide 
a potential model for evaluation of other similar interventions. Because of the priority given to the integrated agenda by governments 
internationally, the need to develop and improve strong evaluation methodologies remains strikingly important.
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The logic of the evaluation
This paper describes the evaluation methodology for 
the NWL ICP, a significant integrated care program 
within a purchaser-provider split, taxpayer-funded 
national health system. Central in developing the 
evaluation plan was to recognise the complexity of the 
intervention in clinical, financial, strategic and political 
contexts. In particular, we see that the intervention tar-
gets “several integrating components” of care. These 
components include inter-professional communica-
tion, incentives for participation and performance and 
the adoption of new technologies and ways of work-
ing. These elements impact on “several groups and 
organisational levels” such as local and national com-
missioning bodies, primary and acute care in both the 
health and social care domains. As such, we locate 
the methodology within the broader theory of complex 
intervention evaluation and we draw from the UK Med-
ical Research Council’s guidance [6].
This evaluation therefore has a deliberately broad 
focus to enable the different facets of the pilot’s con-
sequences to be captured. A quantitative analysis, 
designed to measure activity—and consequently 
impact on cost—within the health system and analysis 
of changes to health outcomes. It also includes qualita-
tive themes, looking at patient, clinician and manager 
experiences to the process of the implementation, the 
barriers to adoption, and wider questions of how the 
pilot fits into the national integration agenda. The four 
streams of the evaluation are described in Table 1, 
where methods of investigation match the core aims 
of the pilot. This evaluation will take place over the first 
year of the pilot, with further evaluation being planned 
for the future.
The ICP itself operates within a dynamic healthcare 
economy in the midst of financial challenges and 
national legislative changes [9, 10]. The underly-
ing shape of the project has been subject to change 
and refinement including expanding to new locations 
and adjusting expectations in terms of its perceived 
outcomes and impact. This has made its evalua-
tion a moving target [11]. We have therefore adapted 
our evaluation to these changes, to fit the on-going 
context.
In addition, the evaluation has not sought to remain 
separate from the pilot process, only publishing find-
ings at a later date. Instead, information from the 
Table 1. What this Integrated Care Pilot evaluation looks at.
Aim of the pilot Evaluation workstreams
Reduce unwarranted service 
utilization and costs
Workstream 1
Measuring service usage patterns in relation to secondary and social care, using a propensity 
matched case control model, allowing cost changes to be understood.
Improve clinical outcomes and quality 
of care
Workstream 2
Using a mixture of clinical process and outcome measures to observe service quality, both in 
primary and secondary care.
Improve patient and professional 
experience
Workstream 3
A mixed methods approach to capture both professional and patient experience of the integrated 
care process. It consists of: 1. Non-participant observations of multidisciplinary meetings, patient 
case conferences and operational meetings; 2. Focus groups with patients and professionals; 3. 
Semi-structured interviews with patients and professionals; 4. A mixed method survey with main 
stakeholders.
Understand the pilot’s position within 
the broader integrated care agenda
Workstream 4
Qualitative analysis looking at the strategic of the nature pilot, including: the type of integration 
produced, analysis within the national policy context and understanding the higher level decision 
making processes involved.
Box 1: Interventions in the North West London Integrated Care Pilot (adapted from Harris et al. 2012) [8]
Early identification of at-risk diabetic or elderly people, including risk stratification using combined predictive model and others •
Proactive care planning and delivery by community teams •
Care planning shared across care settings including clear guidance for out-of-hours services ○
Proactive case management of patients with complex conditions •
 Multidisciplinary teams led by a general practitioner or consultant to ensure that care of patients with complex conditions reduces risk of  ○
hospitalization
Appropriate emergency responses •
Improved ambulance protocols and assessment integrated with care planning and community care ○
Improved information flows and system redesign •
Improved systems and processes to share patient notes and care plans across care settings via a novel technology platform ○
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evaluation process is being fed back to the organisa-
tions taking part in the pilot, and to the pilot’s man-
agement board, regularly during the operation of the 
pilot. In particular, we will feed back findings to the ICP 
board in the form of an interim and a final report, and 
via several evaluation committee meetings en route, 
allowing the ICP management team to respond to find-
ing so far (and potentially act to improve the interven-
tion), and allowing the evaluation team to identify data 
sources and participants. The formative nature of this 
approach may lead to some confounding of our evalu-
ation of the intervention; however the reality of service 
redesign is often that evaluators need to work closely 
with implementers.
The evaluation framework
Workstream 1: Impacts on service use 
and costs
One of the intended consequences of the NWL ICP is 
to change the pattern of service use, and in particular, 
reduce the use of more expensive hospital care by sub-
stituting better preventive and anticipatory care [12]. 
This element of the evaluation will look at the extent to 
which the pattern of health and social care service use 
has changed for patients.
In undertaking this work, we will seek to maximise the 
sample of cases under study by exploiting existing 
administrative information. Though this means that 
the results are influenced by the quality and depth of 
information recorded, the approach does have some 
advantages in that data collection is relatively inex-
pensive. Hence, it becomes possible to look at large 
sample sizes and that for individual-based analyses 
administrative data overcomes problems of recall 
bias when asking people about service use and med-
ical diagnoses. Through linkage of administrative 
data sets, it is also possible to look at how patients 
use resources across organisations including social 
care [13].
The analysis looks at changes and difference in a 
number of metrics of activity. These are the number 
of hospital admissions, out-patient attendances and 
A&E attendances, the estimated costs of these events, 
intensity of social care service use (notional cost per 
person per month), number and estimated cost of 
GP visits and community nursing inputs (where data 
allow). Activity will be costed to weight different forms 
of activity using methods applied in previous work on 
national resource allocation models [14] and in studies 
of social care [15].
One of the key challenges in undertaking analyses of 
changes in hospital use for complex interventions is that 
individuals may be selected for an intervention because 
they have a high use of health services. The problem is 
that any subsequent fall in utilisation in this group may 
simply be due to regression to the mean—that is peo-
ple reverting to a normal level of use irrespective of the 
intervention [16, 17]. This means that simple changes 
over time are not sufficient to show an effect but there 
needs to be some form of control group to show what 
would have happened anyway. Whilst randomised pro-
spective analyses would overcome these problems, 
these were not feasible in this instance due to resource 
constraints. As an alternative, we plan to identify con-
trols through a quasi-experimental design selecting 
from a wider population, a subgroup of matched controls 
that are sufficiently similar to the intervention group with 
respect to a set of baseline variables (age, sex, comor-
bidities and hospital activity up to point of intervention). 
The aim is to derive a control group that is well matched 
on all potential confounder variables so that a statisti-
cally valid inference can be drawn (see Box 2).
The proposed analysis will have two arms
a. Comparison of use of hospital services relative to 
an external control group
In this part of analysis, we will focus on a comparison 
with a control population drawn from other areas in 
England. Information will be available for the individu-
als enrolled in any intervention, and also for the whole 
populations of general practices which are participating 
Box 2: Approaches to identifying matched controls.
There are a range of methods that can be used to select matched control groups though all have the common aim of selecting a subgroup 
of patients who are similar to the patients receiving the intervention with respect to variables recorded for all individuals. The two most 
commonly used methods are the propensity score and the prognostic score. The propensity score is an estimate of the probability that a 
given individual will be recruited to the intervention [18] and summarises a wide range of variables such as age and prior hospital use into 
a single quantity. Balance can be further improved by simultaneously matching on key variables predictive of future health and social care 
utilisation along with the propensity score, using a multivariate distance measure such as the Mahalanobis distance [19] (1).
An alternative strategy for finding controls is to match on the estimated probability of experiencing the outcome (for example, an 
emergency hospital admission), where this is calculated assuming that the intervention is not in place. This score is called the prognostic 
score, and the approach is called prognostic matching [20]. Prognostic matching can be combined with matching on other variables using 
the Mahalanobis distance. The prognostic approach weights variables by how predictive they are of future hospital admissions. As we were 
most concerned with balancing variables that are strongly predictive of future hospital admissions, this helped us prioritize variables in the 
matching, and was our selected matching method [21].
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in the Integrated Care Pilot. The data will be at person 
level but anonymised so that the research team can-
not identify sensitive personal information or individual 
identities. The NHS Information Centre for Health and 
Social Care will act as a trusted third party to handle 
any confidential information and create the anonymised 
linked fields for use by the research team.
The aim will be to look at patterns of hospital use for 
this group compared to matched individuals taken from 
across the country representing changes associated 
with ‘usual care’. We will select five local authorities 
that are the most similar to the NW London population 
using Office for National Statistics (ONS) correspond-
ing health areas methodology [22].
Information on the prior patterns of diagnoses and hos-
pital utilisation will be used to stratify cases according 
to the risk of admission. The actual level of utilisation 
before and after the agreed starting point in the pilot will 
be compared. In this way, we will be able to track lev-
els of hospital use for cohorts of people for 2–3 years 
before they became part of the pilot. We will then test 
for subsequent change and compare results by risk 
strata. Our analysis strategy is built around a general-
ized difference-of-differences regression approach at 
the person level.
This external comparison has the advantage that it 
enables more precise matching as it draws from a 
much larger pool of potential controls. It will also show 
how services within NWL cases have changed with 
respect to usual care in other areas. The main draw-
back is that this approach has to use information com-
mon to cases and controls—which effectively limits the 
analysis to routinely collected hospital based informa-
tion on diagnoses and activity.
b. Comparison of other health and social care 
services change over time
In this arm, we are able to access much more detailed 
sets on health and social care usage for participants 
in the ICP. In the first instance, this allows us to docu-
ment changes in utilization across sectors for a cohort 
of patients. This is useful in ascertaining the relative 
weight of different services in overall costs, and also 
indicating whether change in the use of one service 
is accompanied by change in another. So for example 
is a reduction in hospital bed days in the intervention 
group offset by an increase in social care use? There 
will also be scope to compare pre-post patterns of ser-
vice use specifically linked with different start dates at 
practice level.
We will also explore the extent to which we can derive 
matched controls based in a wider range of local 
data sets—however this requires data for the whole 
populations to be accessible. For some data sets col-
lections may be limited to specific cases only.
Workstream 2: Impacts on clinical 
service quality (process and outcomes)
An important and innovative feature of the ICP is the 
availability of linked, patient-level primary, secondary, 
community health services and social care data to all 
the clinical teams involved, via an Information Portal 
which integrates these data sources. Data integration 
is being recognised as an important intervention in its 
own right in integrated care programmes. The same 
data is being used for the evaluation in anonymised 
form via a Data Sharing Agreement (informed patient 
consent is not required for the secondary use of data 
for clinical audit or NHS service evaluations). Six years’ 
retrospective primary care data and three years’ NHS 
Secondary Uses Service (SUS) data is available for 
analysis. This allows patients’ health and social care 
data to be tracked across sectors and over time, and 
also casemix adjustment for demographic and comor-
bidity covariates.
Because there is a long-standing trend towards 
improved management of chronic diseases in the NHS, 
simply showing that care improved after the introduc-
tion of an ICP would not be sufficient to demonstrate 
their effectiveness. We would need to know that the 
improvement was greater than that based on under-
lying trends and that the improvement was also bet-
ter than in non-ICP settings. This requires data from 
before the introduction of the ICP and also compar-
ing performance against a non-ICP site. Furthermore, 
as this evaluation is being carried out in London, the 
most socio-economically and ethnically diverse part of 
the UK, it is important that the ICP evaluation takes 
into account the characteristics of the populations the 
ICP serves. Also important is to see how well the ICP 
addresses the well-recognized socio-economic and 
ethnic disparities in access to health services and in 
health outcomes.
In addition to service utilization and costs, the evalua-
tion will examine clinical effectiveness, both in terms of 
outcomes and process measures, for the two groups 
(elderly and with diabetes) covered by the ICP. The 
study will look at specific clinical process and outcome 
metrics, described in Table 2, using both time trends 
and a case comparison methodology at the practice 
level, comparing patient data before and after they 
received an ICP care plan and patients in ICP prac-
tices who are eligible for the ICP but have not yet been 
asked for consent or received a care plan. There will 
also be comparisons between local practices that have 
chosen to be a part of the pilot, with those who have not, 
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at the practice level as patient-level primary care data 
is not available for the latter. Specifically, we will exam-
ine whether the introduction of the ICP has resulted 
in improvements in health outcomes for patients with 
diabetes and for older patients.
As the key aim of any health intervention is to improve 
quality of care, patient safety and clinical outcomes, 
these should be key measures in the evaluation. This 
means quantifying the process and outcomes of care. 
For many areas of health care, standards already 
exist (e.g. Quality and Outcomes Framework (QOF), 
National Institute for Health and Clinical Excellence 
(NICE) guidelines). Examples would include HBA1c, 
blood pressure and cholesterol control in people with 
diabetes. Other key areas for quantitative evaluation 
are patient experience and impact on NHS efficiency 
and costs. Impact on NHS efficiency would include 
areas such as unplanned admissions for ambulatory-
sensitive conditions, A&E attendances, and inappro-
priate prescribing, all focusing on specific diseases to 
improve sensitivity, although this must be traded off 
against reductions in numbers of events. We are also 
aiming to measure changes in care processes covered 
by the ICP Care Packages, for example, referrals to 
fall services.
Apart from regarding mortality and utilization of 
unscheduled care as adverse endpoints, there is a 
dearth of available outcome data meaningful to patients. 
The use of disease-specific patient-reported outcome 
measures (PROMs) in primary care is the subject of 
an Oxford pilot funded by the Department of Health. 
However the use of a measure of health-related quality 
of life, such as the EQ-5D, by ICPs would be of great 
utility both for clinical care and evaluation.
In the statistical analysis, we will compare percent-
age differences in annual measurement of the out-
come measures using χ2-tests. Linear regressions for 
pre-ICP data for each patient will be generated with 
a time indicator, and the slope and intercept will be 
used to predict the future value. This value represents 
the expected value of the outcome if the ICP had not 
been established. An additional challenge in the statis-
tical analyses will be to accommodate the hierarchical 
nature of the data, which are years of measurement 
nested within patients nested within practices. Ignor-
ing this multilevel clustering would result in faulty 
Table 2. Clinical outcome and process measures.
Patient 
group
Clinical measure Data source*
Diabetes Speed of referral for recognised foot complications (number of days) GP+SUS OP
Total lower limb amputation incidence (proportion of number of amputations over number 
of patients with diabetes in pilot)
SUS IP
HBA1c, cholesterol and blood pressure control GP+QOF
Prevalence of high global CVD risk (using UKPDS risk engine) GP
Analysis of above indicators by ethnicity and deprivation score quintiles All
Change in EQ5D or diabetes health-related quality of life (HRQoL) score GP
Increase in registered prevalence of diabetes GP+QOF
Increased adherence to diabetes medication (higher proportion of prescriptions filled) GP+prescribing data
Elderly Falls rate among the frail elderly (no. of falls per patient per year) GP
Number of fractures (of any type) (%) SUS OP+SUS IP
Number of patients on care plans as proportion of number who need care plans (%) GP
Number and pattern of all health and social care contacts/attendances. Could include 
scheduled and unscheduled GP practice attendances
GP+SUS OP+SUS 
IP+CHS+social care
Reduction in number of episodes of care and increase in episodes of ‘package’ of care GP+SUS OP+SUS 
IP+CHS+social care
Number of patients with delayed or incomplete actions (% of patients in pilot) GP
Improvement in health-related quality of life (HRQoL) GP
Increases in registered prevalence of QOF diseases common in older people: 
hypertension, atrial fibrillation, dementia, depression and chronic kidney disease
GP+QOF
Uptake of influenza vaccine (coverage is not high) GP
Osteoporosis diagnosis and prevention scheme GP
Registered prevalence of non-QOF diseases affecting elderly (Parkinson’s disease, 
benign prostatic hypertrophy, peripheral vascular disease, fracture of femur, macular 
degeneration, fragility fracture, falls, registered blind/partially sighted/certificate of vision 
impairment)
GP
Patient satisfaction (Overall satisfaction and planning your care domains) for patients 
(responses for those who say they have a long-standing health problem, disability or 
infirmity)
GP patient survey 
practice level data
*GP: General Practice record, SUS IP: Inpatient Secondary Uses Service Data, SUS OP: Outpatient Secondary Uses Service Data, QOF: 
Quality and Outcome Framework.
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estimation of standard errors. We will therefore use 
a random effects multilevel model in this analysis to 
adjust for casemix at the practice level.
A spatial analysis will be also conducted using a Geo-
graphic Information Systems (GIS). Patient data will 
be mapped at the Lower Super Output Area (LSOA) 
to explore the spatial distribution of patients enrolled 
in the ICP compared to controls. Similarly maps will 
be created which display the geographic distribution 
of outcomes, both at practice level and aggregated 
from individual or practice level data as median values 
to LSOA level across the ICP area pre- and post-in-
tervention. The mapping will assist in identifying geo-
graphic areas where there is higher uptake of the ICP 
and allow for monitoring of outcomes over time and 
space to detect where outcomes are affected by spa-
tial factors.
Workstream 3: Qualitative assessment 
of the impact of the Pilot
This part of the study investigates the human per-
ception, experience and involvement of participants 
in the pilot. We hope to develop a comprehensive 
understanding of the patients’, carers’ and profes-
sionals’ experiences and perceptions of the pilot, as 
well as their suggestions for effective implementation. 
The main areas of interest are 1. Patient perception 
of continuity of care; 2. Patient perception of changes 
in clinical decision making; 3. Provider experience of 
communication between professional groups; and 4. 
The role of Multidisciplinary group meetings in the inte-
grated care change management process.
In addressing these broad objectives, we are employ-
ing a mixed methods design. This will include focus 
groups with patients and professionals to understand 
their perceptions and experiences of the pilot and 
semi-structured interviews with a purposive sample 
from both patients and professionals to investigate the 
perceptions of all users. Topic guides for these inter-
views focus on users’ experience of the integrated 
pilot, and their attitudes towards the intervention. We 
will use a thematic approach to explore and integrate 
the findings of this approach [23].
To complement these findings, we will also develop 
and implement a survey to record patient and carer 
experience, and a separate survey of professional 
experiences. Survey questions will explore issues 
such as motivation to take part in the pilot and 
experience of participating, but will also incorporate 
questions specific to themes raised from participant 
interviews and observations, to ensure the sur-
veys reflect the challenges faced by the pilot during 
implementation.
Finally, in this qualitative component, we will include 
a novel analysis of patterns of communication within 
MDG meetings, looking at the nature and direction 
of conversation between participants. MDG meetings 
involve the participation of GPs, hospital consultants, 
community and social service professionals each from 
different organizations within the local health economy 
and are therefore different to MDGs within hospital set-
tings. We will explore whether traditional power rela-
tionships and communication patterns exist and persist 
or are broken down leading to a more integrated way 
of working between the professional groups. Does the 
discussion of the complex clinical cases brought to the 
MDG meeting lead to or foster opportunities to con-
sider the wider health economy and ways to improve 
and identify efficiencies in and between participants’ 
respective organizations? This will involve recording 
and transcribing multidisciplinary group meetings, and 
then coding the utterances that occur. We draw on 
Bale’s validated coding scheme [24] to describe and 
characterize the content of the utterances and the kind 
of interactions that are occurring. We will be explor-
ing whether some professional groups dominate the 
conversations and whether their discussions focus on 
individual patient level detail or broader ways of work-
ing together as a heterogeneous but integrated group. 
A more full description of the methodology of this novel 
approach is available elsewhere [25].
The findings from this component of the evaluation will 
add to our understanding of professional practice in 
integrated care programmes and contribute towards a 
framework of knowledge to inform policy and organi-
sational change processes related to integration, 
enhanced communication and collaborative working.
Workstream 4: Strategic evaluation 
of the pilot within the national policy 
context
The final part of the evaluation has the broadest focus; 
examining how the pilot operates at an organisa-
tional level and how the wider policy environment has 
shaped the design and implementation of the initiative. 
This component also aims to ground the evaluation of 
the pilot in the context of the field of integrated care in 
the NHS and beyond. This workstream complements 
the other workstreams by taking a strategic overview. 
To this end, we aim to explore how national policy has 
impacted upon the design, implementation and opera-
tion of the pilot, identifying factors that have facilitated 
or hindered progress. By locating the pilot within the 
wider literature and evidence base, we hope to draw 
insight from other national and international models of 
integrated care, identifying and exploring areas where 
the pilot appears to be distinctive. We will also examine 
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how the pilot is developing at a strategic level in order 
to understand the organisational level motivations for, 
and challenges of, developing integrated care.
This part of the evaluation will be addressed via a pro-
gramme of on-going policy analysis, observations and 
semi-structured interviews. Interviews are being under-
taken with senior representatives of the key organisa-
tions involved in the pilot. We seek to understand the 
organisational and strategic motivations for engaging 
with the pilot and any challenges and barriers to doing 
so. Interviews also aim to understand how national 
policy and local contextual factors—such as organisa-
tional relationships, financial positions and local prior-
ities—have shaped the design of the pilot and helped 
or hindered its implementation and development. On- 
going consultation with key individuals in the wider pol-
icy arena will ensure that interviews with those involved 
in the pilot address appropriate issues. The policy 
literature will be regularly reviewed to ensure that new 
evidence and emerging issues are taken into account.
Interviewees from all key organisations have been 
identified to ensure the evaluation understands the 
pilot from the perspective of all the different players. 
A number of observations of board meetings, com-
mittee meetings and operational team meetings will 
complement interviews by offering an insight into how 
the pilot is being implemented and highlighting par-
ticular dynamics and challenges at a strategic level. 
Interview and observational data will be analysed by 
qualitative researchers who will identify key themes, 
drawing out the most important barriers and enablers. 
The framework of analysis will be based on the theo-
retical literature of integrated care and the wide body 
of policy literature. Where appropriate, comparisons 
will be made with other examples of integrated care. 
This analysis will add to the body of literature and evi-
dence on the implementation of integrated care initia-
tives, extending our understanding of the challenges 
involved in executing large scale change within a 
dynamic policy environment.
Discussion
Dealing with complexity
The complex nature of the intervention and the environ-
ment will make attribution of cause and effect difficult. 
This pilot is occurring in a period of almost unparal-
leled structural reforms in the English National Health 
Service—many of which may have an impact on the 
desired effect of the pilot. The ICP could be described 
as the introduction of a complex intervention into a 
complex environment—having the characteristics of 
adaptation and learning by both those delivering and 
receiving the intervention, feedback loops, a sensitivity 
to starting conditions and with a diversity of activities 
and emergent outcomes [11, 26].
We are aware of the tension between providing early 
evaluation results to inform decision makers—against 
the need to undertake rigorous analytical methods. 
For example, in some cases changes can only be 
confirmed with large samples and longer follow-up 
periods. In addition, experience from other countries 
shows that successful integrated care organisations 
take many years or decades to develop.
Exploring the counterfactual in this case will conse-
quently be difficult. The presence of control groups 
is reassuring, but comparison against other areas of 
a national health economy where innovation is being 
actively encouraged means that it is difficult to confirm 
if the control groups are genuinely intervention free. At 
best, they represent the average pattern of care seen 
outside of this pilot environment. There are also other 
projects in the same geographical area that might influ-
ence the findings. Year on year comparison is made 
more difficult by the secular trends and on-going struc-
tural changes occurring in the NHS. Furthermore, 
any evaluation that includes clinical outcomes has to 
be timed appropriately, to allow the natural history of 
disease and the effect of interventions on this to take 
its course. Although this plan describes a time limited 
evaluation, relating to cost, an ideal evaluation would 
follow patients and appropriate controls over a pro-
longed period. Given this environment and the complex 
and iterative nature of the intervention, the evaluation 
requires a degree of flexibility in method and process—
to learn and adapt as the intervention does so.
We accept that there are limitations to our approach, 
and that we were not able to move systematically 
though the various stages of evaluating a complex 
intervention that would ideally be done using the MRC’s 
framework, including modelling and delivering a small 
scale proof of concept. However, given the financial 
constraints placed on many innovative delivery models 
in the current period of financial austerity, we suggest 
that this work will provide a useful, real world model for 
others attempting the evaluation of similar schemes.
Strategies we have adopted in the evaluation design to 
mitigate against the various challenges faced are listed 
in Table 3. We appreciate that there are many attempts 
to evaluate complex interventions using mixed methods 
approaches. We believe that this approach adds extra 
depth, beyond simple quantitative aspects of perfor-
mance and qualitative assessment of user experience, 
by measuring integration behaviour and strategic, organ-
isational level experience. This may serve as a useful 
resource for others also embarking on the evaluation of 
complex interventions such as integrated care pilots.
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Table 3. Challenges and responses of this evaluation approach.
Challenge Strategy to mitigate
1 Large population base spread over different 
PCTs
Representative sample of respondents from participating organizations and 
professional groups, including patients from as many PCTs as possible. Use of data 
from all participating GP practices.
2 Involvement of multiple different 
organizations from primary and secondary 
care, to social care and community services
Explore communication patterns across professional boundaries. Interviews with 
senior executives from all participating organizations.
3 Inconsistent implementation and levels of 
involvement from different organizations
Non-participant observation in operations meetings, MDG performance reviews, 
IMB meetings and sub-committee meetings to stay abreast of significant decisions 
and changes to the ICP as it is being implemented. Locating the findings within this 
meso-organizational context
4 Adaptive responses to the pilot 
implementation over time
Non-participant observation of MDG, Independent Monitoring Board and sub-
committee meetings and informal interviews with ICP staff to ascertain early changes 
to systems, processes and structures within participating organizations and to feed 
this into the broader summative evaluation findings
5 Heterogeneous and incomplete data sources Novel linkage of data sets allowing combination of primary care, secondary care and 
social care data
6 Implementation in a region already crowded 
with multiple other interventions each with the 
potential to confound the findings
Identify concurrent programmes within the same geographical area and ascertain the 
reasonable contribution of the ICP to broader health care changes and outcomes; 
triangulation of health outcomes from ICP with interviews with participants, key 
informants and local stakeholders to ascertain views on the impact of the ICP
Conclusion
The proposed methodology, with a focus on looking at 
service usage and quality, and a matched case com-
parison approach will allow a robust assessment of 
effectiveness of a large integrated care intervention 
within the NHS. We believe that the investigation of the 
qualitative aspects, including ways of working, barriers 
to adoption and staff and patient experience, will allow 
us to gain an insight into those ‘softer’ cultural aspects 
of the development of the integrated care model, which 
have often proved so hard to do.
Despite its limitations, we hope this evaluation allows 
us, in the words of Tom Ling, to clarify contribution (how 
reasonable is it to believe that the intervention contrib-
utes to the intended goals effectively) even if it is not 
able to definitely identify attribution (what proportion of 
the desired outcomes was produced by the interven-
tion) [11]. The broad, dynamic and responsive nature 
of the approach should allow some of the inherent com-
plexities to be accounted for. Given the priority given to 
the integrated agenda by governments internationally, 
the need to develop and improve strong evaluation 
methodologies remains strikingly important.
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